$ABCL
AbCellera Biologics Inc. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is ABCL down today? It is at $11.48 (-4.41%), and our scanner flagged it 466 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABCL spikes, and full due diligence on ABCL — key stats, earnings, dilution and insider activity. Free.
Get free $ABCL alerts the moment volume spikes
Our scanner flagged $ABCL 466 times in the last 30 days. Create a free account to track $ABCL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $11.48
- Change today
- -4.41%
- Previous close
- $12.01
- 52-week range
- $2.75 – $12.15
- Market cap
- $3.41B
- Total held
- 30.3%
- Tradeable float
- 213.6M 70% of shares · after 30% insiders + institutional n/a
- Short interest
- 48.3M ▲ +7% vs prior · as of 2026-07-31
- Short % of float
- 22.6%
- Days to cover
- 9.7d
- Avg daily volume
- 5.7M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.0x
- 15m
- 0.2x
- 1h
- 0.7x
- 1D
- 0.2x
Get free ABCL + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ABCL down today?
ABCL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on ABCL today, peaking at 4.3x its normal volume.
Likely catalystPriced share offering, from an SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Insiders
Insiders buying9 open-market buys3 buys, 1 sells last 3 months (8/2 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Montalbano John S. Director | Bought (open market) | +10K | added 4.1% | 251K | $110K at $11.03 | Aug 18, 26 |
Booth Andrew Officer | Bought (open market) | +37K 0.01% of company | added 8.3% | 483K | $384K at $10.32 | Aug 14, 26 |
Hayden Michael R Director | Bought (open market) | +46K 0.02% of company | added 3.3% | 1.44M | $481K at $10.37 | Aug 12, 26 |
Hayden Michael R Director | Sold (automatic/other) | -50K 0.02% of company | sold 3.5% | 1.39M | n/a | Aug 11, 26 |
Booth Andrew Officer | Other | 250K 0.08% of company | added 100% | 446K | $48K at $0.190 | Jun 3, 26 |
Montalbano John S. Director | Bought (open market) | +20K | added 9.0% | 241K | $95K at $4.77 | May 14, 26 |
Booth Andrew Officer | Bought (open market) | +43K 0.01% of company | added 28% | 196K | $146K at $3.42 | Feb 27, 26 |
Thermopylae Holdings Ltd. Beneficial Owner (10%) | Bought (open market) | +38K 0.01% of company | added <0.1% | 56.13M | $131K at $3.44 | Feb 27, 26 |
Thermopylae Holdings Ltd. Beneficial Owner (10%) | Bought (open market) | +177K 0.06% of company | added 0.3% | 56.10M | $580K at $3.27 | Feb 26, 26 |
Thermopylae Holdings Ltd. Beneficial Owner (10%) | Sold (automatic/other) | -225K 0.07% of company | sold 0.4% | 55.92M | n/a | Dec 18, 25 |
Montalbano John S. Director | Bought (open market) | +50K 0.02% of company | added 29% | 221K | $179K at $3.57 | Nov 26, 25 |
Thermopylae Holdings Ltd. Beneficial Owner (10%) | Bought (open market) | +344K 0.1% of company | added 0.6% | 56.14M | $742K at $2.16 | Mar 11, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $ABCL. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$ABCL Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ABCL Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to ABCL
Comparable names in pharmaceutical preparations, closest in size first.
ABCL stock FAQ
Why is $ABCL down today?
ABCL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on ABCL today, peaking at 4.3x its normal volume.
What is the ABCL stock price today?
ABCL last traded at $11.48, down 4.41% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ABCL alerts?
The ABCL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABCL 466 times in the last 30 days.
What exchange is ABCL on?
ABCL (AbCellera Biologics Inc. Common Shares) trades on XNAS, with a market cap of about $3.41B in the PHARMACEUTICAL PREPARATIONS sector.
Is ABCL good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABCL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.